Pharmacyte Biotech shares owned by Vanguard Group
Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Pharmacyte Biotech
Tip: Access up to 7 years of quarterly data
All positions including Pharmacyte Biotech held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pharmacyte Biotech by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $73k | 75k | 0.97 |
| 2025-06-30 | $214k | 194k | 1.10 |
| 2025-03-31 | $243k | 195k | 1.25 |
| 2024-12-31 | $298k | 192k | 1.55 |
| 2024-09-30 | $368k | 192k | 1.91 |
| 2024-06-30 | $377k | 192k | 1.96 |
| 2024-03-31 | $414k | 175k | 2.37 |
| 2023-12-31 | $370k | 171k | 2.16 |
| 2023-09-30 | $355k | 169k | 2.10 |
| 2023-06-30 | $525k | 184k | 2.86 |
| 2023-03-31 | $2.0M | 702k | 2.91 |
| 2022-12-31 | $1.9M | 655k | 2.93 |
| 2022-06-30 | $1.4M | 642k | 2.24 |
| 2022-03-31 | $1.4M | 615k | 2.30 |